Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19
Objectives: With the increasing number of people suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a dire need to look for effective remedies against this pandemic. Drug repurposing seems to be the solution for the cu...
Main Authors: | Asma Tariq, Rana Muhammad Mateen, Muhammad Sohail Afzal, Mahjabeen Saleem |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220304987 |
Similar Items
-
Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease
by: Radwan Alnajjar, et al.
Published: (2020-12-01) -
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
by: Zhen Qiao, et al.
Published: (2020-05-01) -
Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus <i>Aloe</i>: An In Silico Study for Drug Development
by: Mohamed E. Abouelela, et al.
Published: (2021-03-01) -
Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine
by: Ana Teresa Silva, et al.
Published: (2020-07-01) -
In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor
by: Doni Dermawan, et al.
Published: (2021-01-01)